Previous Article | Next Article ![]()
Infection and Immunity, October 2000, p. 5559-5566, Vol. 68, No. 10
Department of Infectious and Tropical
Diseases, London School of Hygiene and Tropical Medicine, London WC1E
7HT, United Kingdom1; Division of
Biochemistry, National Institute for Medical Research, Lagos,
Nigeria2; and Department of Immunology,
Walter Reed Army Institute of Research, Silver Spring, Maryland
209103
Received 22 May 2000/Returned for modification 10 June
2000/Accepted 4 July 2000
Invasion of human erythrocytes by Plasmodium falciparum
merozoites is a multistep process. For many strains of the parasite, part of this process requires that the erythrocyte binding antigen 175 (EBA-175) of the merozoite binds to sialic acid residues of glycophorin
A on the erythrocyte surface, a receptor-ligand interaction which
represents a potential target for inhibition by antibodies. This study
characterizes the reactivity of naturally acquired human antibodies
with four recombinant proteins representing parts of EBA-175 (region
II, regions III to V, and the dimorphic C and F segment region) in
populations in which the organism is endemic. Serum immunoglobulin G
(IgG) recognizing the recombinant proteins is predominantly of the IgG1
and IgG3 subclasses, and its prevalence increases with age. In a large
population study in The Gambia, serum positivity for IgG or IgG1 and
IgG3 subclass antibodies to each of the EBA-175 recombinant antigens
was not significantly associated with subsequent protection from
clinical malaria. However, there was a trend indicating that
individuals with high levels of IgG to region II may have some protection.
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Analysis of Human Antibodies to Erythrocyte Binding
Antigen 175 of Plasmodium falciparum
*
Corresponding author. Mailing address: Department of
Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel St., London WC1E 7HT, United Kingdom. Phone: 44-20-7927-2331. Fax: 44-20-7636 8739. E-mail:
david.conway{at}lshtm.ac.uk.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|